U.S. Markets open in 4 hrs 38 mins

Leap Therapeutics Inc (LPTX) CEO, President, Chairman Christopher Mirabelli Bought $999,999 of ...

- By insider

CEO, President, Chairman of Leap Therapeutics Inc (LPTX) Christopher Mirabelli bought 571,428 shares of LPTX on 02/05/2019 at an average price of $1.75 a share. The total cost of this purchase was $999,999.

Leap Therapeutics Inc is a biopharmaceutical company . The company is engaged in acquiring and developing novel therapeutics at the leading edge of cancer biology. Leap Therapeutics Inc has a market cap of $21.160 million; its shares were traded at around $1.44 .


CEO Recent Trades:

  • CEO, President, Chairman, 10% Owner Christopher Mirabelli bought 571,428 shares of LPTX stock on 02/05/2019 at the average price of $1.75. The price of the stock has decreased by 17.71% since.

CFO Recent Trades:

  • CFO, GC, Treasurer & Secretary, 10% Owner Douglas E Onsi bought 571,428 shares of LPTX stock on 02/05/2019 at the average price of $1.75. The price of the stock has decreased by 17.71% since.

Directors and Officers Recent Trades:

  • COO, 10% Owner Augustine Lawlor bought 571,428 shares of LPTX stock on 02/05/2019 at the average price of $1.75. The price of the stock has decreased by 17.71% since.
  • 10% Owner Ventures Ix, L.p. Healthcare bought 571,428 shares of LPTX stock on 02/05/2019 at the average price of $1.75. The price of the stock has decreased by 17.71% since.

For the complete insider trading history of LPTX, click here

.This article first appeared on GuruFocus.